Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

BACKGROUND: The efficacy and safety of disease-modifying therapies (DMTs) in multiple sclerosis (MS) are well known; however, owing to their high costs, determining real-world outcomes is essential to evaluate the cost-effectiveness of different therapeutic strategies. This study aimed to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero-Pinel, Lucía, Bau, Laura, Matas, Elisabet, León, Isabel, Juvany, Roser, Jódar, Ramon, Martínez-Yélamos, Antonio, Martínez-Yélamos, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053779/
https://www.ncbi.nlm.nih.gov/pubmed/35486620
http://dx.doi.org/10.1371/journal.pone.0267504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053779/
https://www.ncbi.nlm.nih.gov/pubmed/35486620
http://dx.doi.org/10.1371/journal.pone.0267504

Ejemplares similares